Over the past decade, environmental, social and governance (ESG) topics have featured heavily in social and political discourse. ESG has also become prominent in the boardroom as directors navigate how best to address...more
3/29/2024
/ Board of Directors ,
Books & Records ,
Climate Change ,
Commercial Litigation ,
Controlling Stockholders ,
Corporate Governance ,
Disclosure Requirements ,
Diversity and Inclusion Standards (D&I) ,
Environmental Social & Governance (ESG) ,
Greenhouse Gas Emissions ,
New Rules ,
Regulatory Oversight ,
Securities and Exchange Commission (SEC) ,
Securities Regulation ,
Shareholder Activism ,
Shareholder Proposals
In October 2023, Chancellor Kathaleen St. J. McCormick of the Court of Chancery addressed an issue of first impression in Crispo v. Musk, C.A. No 2022-0666-KSJM, holding that “a provision purporting to define a target...more
Chelsea Therapeutics: Post-Closing Bad Faith Claim a ‘Rare Bird’ in Delaware Absent Allegations of Self-Interestedness or Lack of Independence -
In In re Chelsea Therapeutics International LTD Stockholders Litigation,...more
11/18/2016
/ Acquisitions ,
Bad Faith ,
Board of Directors ,
Breach of Duty ,
Controlling Stockholders ,
Dismissals ,
Duty of Loyalty ,
Failure To Disclose ,
Financial Adviser ,
Going-Private Transactions ,
Life Sciences ,
Mergers ,
Minority Shareholders ,
Motion to Dismiss ,
Pharmaceutical Industry ,
Pleadings ,
Preliminary Injunctions ,
Proxy Statements ,
Sale of Assets ,
Shareholder Litigation ,
Special Committees